CD36, also known as fatty acid translocase, is associated with fatty acid uptake interacting with lipoproteins and long-chain fatty acids, such as FABP3. Previous studies have shown that overexpression of CD36 results in elevated fatty acid uptake and promotion of a more aggressive epithelial-mesenchymal transition (EMT) phenotype in a number of cancers, including hepatocellular carcinoma23. Here, CD36 is linked to cancer.